Baldwin Insurance Group (NASDAQ:BWIN) Stock Rating Lowered by Wall Street Zen

Baldwin Insurance Group (NASDAQ:BWIN - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Saturday.

Several other research firms also recently issued reports on BWIN. Jefferies Financial Group lifted their price target on shares of Baldwin Insurance Group from $41.00 to $42.00 and gave the company a "hold" rating in a research report on Friday, April 11th. BMO Capital Markets reduced their price target on shares of Baldwin Insurance Group from $51.00 to $50.00 and set an "outperform" rating for the company in a research report on Friday, June 13th. Wells Fargo & Company lifted their price target on shares of Baldwin Insurance Group from $33.00 to $34.00 and gave the company an "underweight" rating in a research report on Thursday, April 10th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $45.00 price target (up previously from $39.00) on shares of Baldwin Insurance Group in a research report on Tuesday, April 8th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $44.83.

Baldwin Insurance Group Stock Performance

NASDAQ BWIN opened at $39.91 on Friday. The company has a fifty day simple moving average of $39.95 and a 200 day simple moving average of $40.69. Baldwin Insurance Group has a 12-month low of $32.46 and a 12-month high of $55.82. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.43. The company has a market cap of $4.73 billion, a P/E ratio of -76.75, a PEG ratio of 1.50 and a beta of 1.65.

Insider Buying and Selling at Baldwin Insurance Group

In other news, Director Lowry Baldwin sold 62,500 shares of Baldwin Insurance Group stock in a transaction on Monday, May 12th. The stock was sold at an average price of $39.00, for a total transaction of $2,437,500.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Trevor Baldwin sold 58,000 shares of Baldwin Insurance Group stock in a transaction on Wednesday, June 11th. The stock was sold at an average price of $38.48, for a total value of $2,231,840.00. Following the sale, the chief executive officer now owns 144,676 shares in the company, valued at $5,567,132.48. The trade was a 28.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 451,380 shares of company stock worth $17,731,131. Corporate insiders own 18.51% of the company's stock.

Institutional Investors Weigh In On Baldwin Insurance Group

A number of hedge funds have recently made changes to their positions in BWIN. Rhumbline Advisers bought a new stake in shares of Baldwin Insurance Group during the 4th quarter worth $3,476,000. State of New Jersey Common Pension Fund D bought a new stake in shares of Baldwin Insurance Group during the 4th quarter worth $1,840,000. Principal Financial Group Inc. bought a new stake in shares of Baldwin Insurance Group during the 4th quarter worth $2,320,000. Truist Financial Corp bought a new stake in shares of Baldwin Insurance Group during the 4th quarter worth $397,000. Finally, Venturi Wealth Management LLC bought a new stake in shares of Baldwin Insurance Group during the 4th quarter worth $66,000. 77.49% of the stock is currently owned by institutional investors.

Baldwin Insurance Group Company Profile

The Baldwin Insurance Group, Inc operates as an independent insurance distribution firm that delivers insurance and risk management solutions in the United States. It operates through three segments: Insurance Advisory Solutions; Underwriting, Capacity & Technology Solutions; and Mainstreet Insurance Solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.